Erythematosus Patients Gene in African American Systemic Lupus BackgroundLigand Expression : A Candidate Gene Promoter Alters Fas FasL in the Element β CAAT / Enhancer-Binding Protein A Novel Polymorphic

[1]  M. Greenberg,et al.  Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. , 2001, Immunity.

[2]  Y. Shoshan,et al.  Accelerated Fas-Mediated Apoptosis of Monocytes and Maturing Macrophages from Patients with Systemic Lupus Erythematosus: Relevance to In Vitro Impairment of Interaction with iC3b-Opsonized Apoptotic Cells1 , 2001, The Journal of Immunology.

[3]  P. Fink,et al.  The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Christopher C. Goodnow,et al.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.

[5]  D. Mevorach.  The Immune Response to Apoptotic Cells , 1999, Annals of the New York Academy of Sciences.

[6]  F. Rieux-Laucat,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Lymphoproliferative Syndrome With Autoimmunity: A Possible Genetic Basis for Dominant Expression of the Clinical Manifestations , 2022 .

[7]  P. Krammer,et al.  Novel Egr/NF‐AT composite sites mediate activation of the CD95 (APO‐1/Fas) ligand promoter in response to T cell stimulation , 1999, European journal of immunology.

[8]  Pingar Yang,et al.  Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. , 1999, Journal of immunology.

[9]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[10]  P. Gaffney,et al.  A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Petri,et al.  Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Krammer,et al.  A regulatory element in the CD95 (APO‐1/Fas) ligand promoter is essential for responsiveness to TCR‐mediated activation , 1998, European journal of immunology.

[13]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[14]  J. Ashwell,et al.  Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression , 1998, Molecular and Cellular Biology.

[15]  Andrew D. Badley,et al.  Transcriptional Regulation of the Human FasL Promoter-Enhancer Region* , 1998, The Journal of Biological Chemistry.

[16]  R. Bucala,et al.  Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. , 1998, Journal of immunology.

[17]  S. Eliason,et al.  Two NFAT Transcription Factor Binding Sites Participate in the Regulation of CD95 (Fas) Ligand Expression in Activated Human T Cells* , 1997, The Journal of Biological Chemistry.

[18]  R. Bucala,et al.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Jaffe,et al.  Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. , 1997, Blood.

[20]  G. Tsokos,et al.  Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. , 1997, Autoimmunity.

[21]  K. Elkon,et al.  B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. , 1996, Current opinion in immunology.

[22]  P. Schur,et al.  Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. , 1996, The Journal of clinical investigation.

[23]  E. Lacy,et al.  Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Cortese,et al.  Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.

[25]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[26]  A. Tsutsumi,et al.  Up‐regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia , 1995, Clinical and Experimental Immunology.

[27]  Nobuaki Yoshida,et al.  Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.

[28]  R. Bucala,et al.  Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.

[29]  J. Inazawa,et al.  Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.

[30]  A. Abbas,et al.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.

[31]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[32]  P. Krammer,et al.  The apoptosis-1/Fas protein in human systemic lupus erythematosus. , 1994, The Journal of clinical investigation.

[33]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[34]  J. Papaconstantinou,et al.  Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. , 1992, The Journal of biological chemistry.

[35]  R. Cortese,et al.  IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C EBP , 1990, Cell.

[36]  C. Steinman,et al.  Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. , 1990, The Journal of clinical investigation.

[37]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[38]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[39]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.